INTRODUCTION

9
The gastric pathogen H. pylori infects about half of all humans (15,22), causes ulcers (14) and 10 gastric adenocarcinomas (4,7). To cure H. pylori infection a combined treatment with 11 antibiotics and a proton pump inhibitor for gastric acid suppression is used. Despite frequent 12 administration in conventional triple therapies (12) and the sequential therapies currently 13 being developed (8,9,13,23), the effect of PPIs in therapy for this infection is poorly 14 understood. A finding of major importance was that combined treatment with a PPI causes an 15 increased concentration of the regularly used antibiotic clarithromycin in the gastric mucus 16 (11). Due to the interdependent regulation of acid and mucus secretion, a PPI may reduce 17 mucus secretion (10). In the case of substances with low gastric clearance rates, decreased 18 mucus secretion after administration of a PPI could enhance their concentration in the mucus. 19
However, this observation does not explain the mechanism of action of PPIs, since antibiotic 20 schemes without the macrolide clarithromycin (using, e.g., the well-penetrating 21 fluoroquinolone moxifloxacin (1,16)) are similarly effective. After the last injection, the bacterial distribution in the mucus was measured in nanoliter 35 samples of mucus from the antrum region to determine the number of colonizing bacteria. 36
Using digital microscopic imaging, it was possible to reconstruct the bacterial distribution 37 with respect to the tissue surface as previously described (19, 21) . that the bacteria had spread into these more luminal mucus layers (Table 1) . 50 - Table 1 Table A2 ). These observations may result from a modification of the bicarbonate-dependent 64 mucus pH gradient, which guides H. pylori orientation within the gastric mucus layer (19) . Dependent on the actual pH, remaining activity of pepsin C in the lumen causes a loss of 88 H. pylori motility (17,18), the bacteria are irretrievably lost and the bacterial load is reduced. 89
In contrast, two subsequent PPI administrations in shorter time intervals, in which the gastric 90 pH remained neutralized, had no effect on H. pylori orientation. Therefore, the time course of 91 the gastric lumen pH that was particularly fatal for bacterial orientation was characterized by 92 a recovery of acid secretion after the last PPI dose and a rapid neutralization following the 93 next dose. These experimental data match the remarkable clinical observations that lower 94 doses (2) or lower frequencies (5) 
